Losartan Potassium/Lipoic acid

氯沙坦钾/硫辛酸

Report date: 2022/07/19 16:22:54

Base Information

Drug NameLosartan Potassium/Lipoic acid
Drug Alias NameLipoic acid/Losartan Potassium氯沙坦钾硫辛酸硫辛酸氯沙坦钾Lipoic acid and Losartan Potassium硫辛酸/氯沙坦钾 +[9
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInvasc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInvasc Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Hypertension

Other Information

ATC CodeN/A
Related LinksN/A